{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T21:52:29Z","timestamp":1788558749039,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ajoc.2023.101839","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T21:06:42Z","timestamp":1680296802000},"page":"101839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Twelve-year outcome of Rho-associated protein kinase inhibitor eye drop treatment for Fuchs endothelial corneal dystrophy: A case study"],"prefix":"10.1016","volume":"30","author":[{"given":"Yasufumi","family":"Tomioka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kitazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Fukuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morio","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Sotozono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6839-251X","authenticated-orcid":false,"given":"Shigeru","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ajoc.2023.101839_bib1","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1097\/ICO.0000000000001694","article-title":"Moderately long-term safety and efficacy of repeat penetrating keratoplasty","volume":"37","author":"Kitazawa","year":"2018","journal-title":"Cornea"},{"issue":"7","key":"10.1016\/j.ajoc.2023.101839_bib2","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.ophtha.2016.03.011","article-title":"Descemet stripping endothelial keratoplasty: ten-year endothelial cell loss compared with penetrating keratoplasty","volume":"123","author":"Price","year":"2016","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajoc.2023.101839_bib3","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/01.ico.0000214224.90743.01","article-title":"Descemet-stripping automated endothelial keratoplasty","volume":"25","author":"Gorovoy","year":"2006","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.ajoc.2023.101839_bib4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ajo.2007.09.021","article-title":"Preliminary clinical results of Descemet membrane endothelial keratoplasty","volume":"145","author":"Melles","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajoc.2023.101839_bib5","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMoa1712770","article-title":"Injection of cultured cells with a ROCK inhibitor for bullous keratopathy","volume":"378","author":"Kinoshita","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ajoc.2023.101839_bib6","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ophtha.2020.09.002","article-title":"Five-year follow-up of first 11 patients undergoing injection of cultured corneal endothelial cells for corneal endothelial failure","volume":"128","author":"Numa","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2023.101839_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajo.2021.11.012","article-title":"Superiority of mature differentiated cultured human corneal endothelial cell injection therapy for corneal endothelial failure","volume":"237","author":"Ueno","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajoc.2023.101839_bib8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/APO.0000000000000530","article-title":"Current advancements in corneal cell-based therapy","volume":"11","author":"Kitazawa","year":"2022","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"10","key":"10.1016\/j.ajoc.2023.101839_bib9","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1097\/ICO.0000000000000915","article-title":"Treatment of Fuchs endothelial dystrophy by descemet stripping without endothelial keratoplasty","volume":"35","author":"Borkar","year":"2016","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.ajoc.2023.101839_bib10","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.ajo.2011.12.012","article-title":"Descemet membrane endothelial keratoplasty versus descemet stripping automated endothelial keratoplasty","volume":"153","author":"Tourtas","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajoc.2023.101839_bib11","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/ICO.0000000000001209","article-title":"Descemetorhexis without grafting for Fuchs endothelial dystrophy-supplementation with topical ripasudil","volume":"36","author":"Moloney","year":"2017","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.ajoc.2023.101839_bib12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/ICO.0000000000001883","article-title":"Use of topical rho kinase inhibitors in the treatment of Fuchs dystrophy after descemet stripping only","volume":"38","author":"Macsai","year":"2019","journal-title":"Cornea"},{"issue":"8","key":"10.1016\/j.ajoc.2023.101839_bib13","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/ICO.0b013e318285475d","article-title":"Rho-associated kinase inhibitor eye drop treatment as a possible medical treatment for Fuchs corneal dystrophy","volume":"32","author":"Koizumi","year":"2013","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.ajoc.2023.101839_bib14","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nbt1310","article-title":"A ROCK inhibitor permits survival of dissociated human embryonic stem cells","volume":"25","author":"Watanabe","year":"2007","journal-title":"Nat Biotechnol"},{"issue":"7","key":"10.1016\/j.ajoc.2023.101839_bib15","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/bjo.2010.194571","article-title":"Enhancement of corneal endothelium wound healing by Rho-associated kinase (ROCK) inhibitor eye drops","volume":"95","author":"Okumura","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajoc.2023.101839_bib16","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1167\/iovs.12-11320","article-title":"The ROCK inhibitor eye drop accelerates corneal endothelium wound healing","volume":"54","author":"Okumura","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.ajoc.2023.101839_bib17","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1097\/ICO.0000000000002642","article-title":"A close look at the clinical efficacy of rho-associated protein kinase inhibitor eye drops for Fuchs endothelial corneal dystrophy","volume":"40","author":"Kinoshita","year":"2021","journal-title":"Cornea"},{"key":"10.1016\/j.ajoc.2023.101839_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ajo.2020.12.006","article-title":"Potential functional restoration of corneal endothelial cells in Fuchs endothelial corneal dystrophy by ROCK inhibitor (ripasudil)","volume":"224","author":"Schlotzer-Schrehardt","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajoc.2023.101839_bib19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1167\/iovs.63.4.22","article-title":"Repressed miR-34a expression dictates the cell fate to corneal endothelium failure","volume":"63","author":"Hamuro","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.ajoc.2023.101839_bib20","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/jamaophthalmol.2018.2031","article-title":"Association of the gutta-induced microenvironment with corneal endothelial cell behavior and demise in Fuchs endothelial corneal dystrophy","volume":"136","author":"Kocaba","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajoc.2023.101839_bib21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/bjophthalmol-2019-315776","article-title":"Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation","volume":"105","author":"Maruyama","year":"2021","journal-title":"Br J Ophthalmol"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993623000476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993623000476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:59:54Z","timestamp":1762527594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993623000476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":21,"alternative-id":["S2451993623000476"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2023.101839","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Twelve-year outcome of Rho-associated protein kinase inhibitor eye drop treatment for Fuchs endothelial corneal dystrophy: A case study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2023.101839","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101839"}}